Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

  • End date
    Jan 1, 2024
  • participants needed
  • sponsor
    Dana-Farber Cancer Institute
Updated on 9 February 2022
prostate specific antigen
serum testosterone


The purpose of this phase II trial is to determine the efficacy and safety of testosterone replacement therapy (TRT) in improving the symptoms of androgen deficiency and health-related quality of life in men with prostate cancer who have undergone radical prostatectomy.


The overall objective is to conduct a proof-of-concept double-blind, placebo-controlled, parallel group, randomized trial to determine the efficacy and safety of testosterone replacement therapy (TRT) in improving the symptoms of androgen deficiency (sexual symptoms, low energy, and physical dysfunction) and overall health-related quality of life in men with prostate cancer who have undergone radical prostatectomy for organ-localized disease (pT2,N0,M0), Gleason score < 7 (3+4), who have undetectable PSA (<0.1 ng/mL using a sensitive PSA assay) for > 2 years after radical prostatectomy, and who have androgen deficiency.

Condition Prostate Cancer
Treatment Placebo, Testosterone Cypionate 100 MG/ML
Clinical Study IdentifierNCT03716739
SponsorDana-Farber Cancer Institute
Last Modified on9 February 2022


Yes No Not Sure

Inclusion Criteria

Men with prostate cancer, who have Stage pT2, N0, M0 lesions (confined to the
gland); Combined Gleason score of 7 (3+4 elements) or less; Preoperative PSA
less than 10 ng/ml; Stable and undetectable PSA level (PSA less than 0.1 ng/mL
using an assay that has a functional sensitivity of 0.1 ng/mL) for at least
two years after radical prostatectomy
Age: 40 years and older
Presence of symptoms related to sexual dysfunction, fatigue/low vitality, or physical dysfunction
An average of two fasting, early morning serum testosterone levels, measured by LC-MS/MS, less than 275 mg/dL and/or free testosterone by equilibrium dialysis <60 pg/mL. middle-aged and older men with mean testosterone levels > 300 ng/dL
Ability and willingness to provide informed consent

Exclusion Criteria

Men who have undergone radiation therapy
Men receiving androgen deprivation therapy will be excluded
Hemoglobin <10 g/dL or >16.5 g/dL
Severe untreated sleep apnea
Allergy to sesame oil
Uncontrolled heart failure
Myocardial infarction, acute coronary syndrome, revascularization surgery, or stroke within 3 months
Serum creatinine >2.5 mg/dL; ALT 3x upper limit of normal
Hemoglobin A1c >7.5% or diabetes requiring insulin therapy
Body mass index (BMI) >40 kg/m2
Untreated depression. Subjects with depression who have been on stable anti-depressant medication, or undergoing CBT for more than three months are eligible
Men with axis I psychiatric disorder, such as schizophrenia, will be excluded
Subjects who have used the following medications within the past 6 months: testosterone, DHEA, estrogens, GnRH analogs, antiandrogens, spironolactone, ketoconazole, rhGH, megestrol acetate, prednisone 20 mg daily or equivalent doses of other glucocorticoids for more than two weeks
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note